Stay up to date on the latest company news:
18 March 2024

Abalos selected for funding project by KMU-innovativ, an initiative from Germany‘s Federal Ministry of Education and Research (BMBF)

18 October 2022

Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer

12 August 2022

Abalos Therapeutics---arenaviruses take on cancer

14 October 2021

Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million

05 February 2020

Abalos Therapeutics Expands Leadership Team with Drug Development and Viral Therapy Manufacturing Experts

15 October 2019

Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer


Want to get in touch with the Abalos Therapeutics Team? Meet us at the following events:
May 12-14, 2024

24th Bio€quity Europe

Location: San Sebastián, Spain

Event website

Consent Management Platform by Real Cookie Banner